The pros and cons of transdermal nicotine therapy
- 1 February 1994
- journal article
- review article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 160 (3) , 152-159
- https://doi.org/10.5694/j.1326-5377.1994.tb126568.x
Abstract
Objective To review current knowledge of the efficacy, safety and cost of transdermal nicotine therapy for smoking cessation. Data sources and study selection 1. Published and unpublished reports ...Keywords
This publication has 28 references indexed in Scilit:
- Cholesterol lowering and mortality: the importance of considering initial level of risk.BMJ, 1993
- Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.BMJ, 1993
- Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.BMJ, 1993
- Randomised controlled trial of nasal nicotine spray in smoking cessationThe Lancet, 1992
- Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind studyArchives of internal medicine (1960), 1991
- Nicotine-Replacement Therapy With Use of a Transdermal Nicotine Patch—a Randomized Double-Blind Placebo-Controlled TrialMayo Clinic Proceedings, 1990
- Measuring the Heaviness of Smoking: using self‐reported time to the first cigarette of the day and number of cigarettes smoked per dayBritish Journal of Addiction, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smokingJAMA, 1986
- Effect of various regimens of chronic and acute nicotine exposure on myocardial infarct size in the dogThe American Journal of Cardiology, 1985